Edwards Lifesciences (EW): חוב כולל להון

Driven by unique technologies, Edwards Lifesciences (EW) possesses significant pricing power, dictating supply terms. On the GURU.Markets platform, the company's debt-to-equity ratio reflects borrowing dynamics, where 0.07 represents the latest metric reading. Despite pressure from major healthcare behemoths, the company maintains its position through colossal R&D investments and the development of advanced cardiac systems.

For an investor in Edwards Lifesciences (EW), this indicator serves as a measure of financial stability within the high-tech sector. By analyzing the ratio of total liabilities to shareholders' equity, we assess the proportion of borrowed funds within the financing structure. Low leverage confirms the fundamental reliability of the business. Such a strategy minimizes risks when scaling through a network of external contractors. This guarantees production stability for components without an excessive debt burden.